Sage Therapeutics, Inc. (SAGE) SEC filings
SAGE SEC filings moved a median of -0.11% by the close. SAGE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SAGE overview →
54 measured SAGE SEC filing events.
Where these SAGE SEC filings landedvs 48 measured SAGE SEC filing reactions
| Middle 50% of SAGE SEC filing reactions | -1.92% to +1.98% |
|---|---|
| Median reaction (to close) | -0.11% |
| Measured reactions | 48 |
Point-in-time · zero look-ahead
Half of the 48 SAGE SEC filing events with a measured close landed between -1.92% and +1.98%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Sage Therapeutics, Inc. | SEC filing · Form 15-12G | — | — | |
| Form POSASR Sage Therapeutics, Inc. | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Sage Therapeutics, Inc. | SEC filing · Form S-8 | — | — | |
| Form 8-K Sage Therapeutics, Inc. For: Jul 30 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Sage Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Sage Therapeutics, Inc. For: Jul 30 | SEC filing · Form 8-K | — | — | |
| Form 8-K Sage Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | +0.23% | -0.11% | |
| Form 8-K Sage Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | +0.23% | -0.11% | |
| Form 10-Q Sage Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.93% | -2.80% | |
| Form 8-K Sage Therapeutics, Inc. For: Apr 29 | SEC filing · Form 8-K | +0.93% | -2.80% | |
| Form ARS Sage Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.03% | +0.78% | |
| Form DEF 14A Sage Therapeutics, Inc. For: Apr 23 | SEC filing · Form DEF | +1.03% | +0.78% | |
| Form DEFA14A Sage Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.03% | +0.78% | |
| Form 8-K Sage Therapeutics, Inc. For: Mar 03 | SEC filing · Form 8-K | +0.84% | +5.45% | |
| Form 10-K Sage Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.56% | +0.56% | |
| Form 8-K Sage Therapeutics, Inc. For: Feb 11 | SEC filing · Form 8-K | +0.56% | +0.56% | |
| Form POS AM Sage Therapeutics, Inc. | SEC filing · Form POS | +0.56% | +0.56% | |
| Form POSASR Sage Therapeutics, Inc. | SEC filing · Form POSASR | +0.56% | +0.56% | |
| Form 8-K Sage Therapeutics, Inc. For: Jan 27 | SEC filing · Form 8-K | +0.41% | +2.34% | |
| Form 8-K Sage Therapeutics, Inc. For: Jan 10 | SEC filing · Form 8-K | -1.95% | -2.60% | |
| Form 8-K Sage Therapeutics, Inc. For: Nov 22 | SEC filing · Form 8-K | +0.35% | -3.98% | |
| Form 8-K Sage Therapeutics, Inc. For: Nov 20 | SEC filing · Form 8-K | -2.53% | +3.37% | |
| Form 8-K Sage Therapeutics, Inc. For: Oct 31 | SEC filing · Form 8-K | +0.84% | -1.86% | |
| Form 10-Q Sage Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.73% | -16.25% | |
| Form 8-K Sage Therapeutics, Inc. For: Oct 29 | SEC filing · Form 8-K | +2.73% | -16.25% | |
| Form 8-K Sage Therapeutics, Inc. For: Oct 14 | SEC filing · Form 8-K | -5.24% | -0.55% | |
| Form 8-K Sage Therapeutics, Inc. For: Oct 08 | SEC filing · Form 8-K | +3.33% | +7.17% | |
| Form 8-K Sage Therapeutics, Inc. For: Sep 20 | SEC filing · Form 8-K | -0.14% | +0.99% | |
| Form S-3ASR Sage Therapeutics, Inc. | SEC filing · Form S-3ASR | +0.52% | -1.44% | |
| Form 10-Q Sage Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.32% | -8.44% | |
| Form 8-K Sage Therapeutics, Inc. For: Jul 31 | SEC filing · Form 8-K | -4.32% | -8.44% | |
| Form 8-K Sage Therapeutics, Inc. For: Jul 24 | SEC filing · Form 8-K | +3.35% | +3.70% | |
| Form S-8 Sage Therapeutics, Inc. | SEC filing · Form S-8 | -1.38% | -0.28% | |
| Form 8-K Sage Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | -0.69% | -0.46% | |
| Form 8-K Sage Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | -2.55% | -1.85% | |
| Form 10-Q Sage Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.08% | -0.29% | |
| Form 8-K Sage Therapeutics, Inc. For: Apr 25 | SEC filing · Form 8-K | +3.08% | -0.29% | |
| Form ARS Sage Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +3.08% | -0.29% | |
| Form DEF 14A Sage Therapeutics, Inc. For: Jun 10 | SEC filing · Form DEF | +3.08% | -0.29% | |
| Form DEFA14A Sage Therapeutics, Inc. | SEC filing · Form DEFA14A | +3.08% | -0.29% | |
| Form 8-K Sage Therapeutics, Inc. For: Apr 16 | SEC filing · Form 8-K | +2.05% | +3.09% | |
| Form 8-K Sage Therapeutics, Inc. For: Apr 17 | SEC filing · Form 8-K | -6.64% | -3.01% | |
| Form 8-K Sage Therapeutics, Inc. For: Mar 20 | SEC filing · Form 8-K | -0.96% | -3.27% | |
| Form 10-K Sage Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.89% | +1.98% | |
| Form 8-K Sage Therapeutics, Inc. For: Feb 14 | SEC filing · Form 8-K | -2.89% | +1.98% | |
| Form S-8 Sage Therapeutics, Inc. | SEC filing · Form S-8 | -2.89% | +1.98% | |
| Form 8-K Sage Therapeutics, Inc. For: Jan 31 | SEC filing · Form 8-K | -0.70% | +0.97% | |
| Form 8-K Sage Therapeutics, Inc. For: Jan 22 | SEC filing · Form 8-K | +1.98% | -2.12% | |
| Form 8-K Sage Therapeutics, Inc. For: Jan 04 | SEC filing · Form 8-K | -0.26% | +18.23% | |
| Form DEF 14A Sage Therapeutics, Inc. For: Jan 31 | SEC filing · Form DEF | +0.28% | +3.54% | |
| Form DEFA14A Sage Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.28% | +3.54% | |
| Form PRE 14A Sage Therapeutics, Inc. For: Jan 31 | SEC filing · Form PRE | -0.05% | -3.61% | |
| Form 10-Q Sage Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +6.52% | +8.87% | |
| Form 8-K Sage Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +6.52% | +8.87% |
Keep exploring
More SAGE: earnings → · analyst actions → · SAGE overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Natera, Inc. (NTRA) | 957 | +0.21% | 57% |
| Antares Pharma, Inc. (ATRS) | 951 | 0.00% | 43% |
| Geron Corporation (GERN) | 949 | -0.28% | 41% |
| Intellia Therapeutics, Inc. (NTLA) | 948 | -0.24% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.